Hyun-Hee Shin

Lab researcher & manager (2010. 10 - 2014.11)

Current: researcher at UNIST

8. Ra, J.S., Shin, H., Kang, S., and Do, Y. Lumazine synthase protein cage nanoparticles as antigen delivery nanoplatforms for dendritic cell-based vaccine development. Clin. Exp. Vaccine Res. 2014, 3, 227-234.

7. #Han, J., #Kang, Y. J., Shin, C., Ra J., Shin, H., Hong, S. Y., Do, Y., and Kang, S. Ferritin Protein Cage Nanoparticles as Versatile Antigen Delivery Nanoplatforms for Dendritic (DC)-based Vaccine Development. Nanomed-Nanotechnol. 2014, 10, 561-569.

6. Min, J., Moon, H., Yang, H. J., Shin H. Hong, S. Y., and Kang, S. Development of P22 Viral Capsid Nanocomposites as Anti-cancer Drug, Bortezomib (BTZ), Delivery Nanoplatforms. Macromol. Biosci. 2014, 14, 557-564.

5. Min, J., Jung, H., Shin, H., Cho, G., Cho, H., and Kang, S., Implementation of P22 Viral Capsids as Intravascular MR T1 Contrast Conjugates via Site-selective Attachment of Gd (III)-chelating agents. Biomacromolecules, 2013, 14, 2332-2339.

4. Moon, H., Kim, W. G., Lim S., Kang, Y. J., Shin, H., Ko, H., Hong, S. Y., and Kang, S., Fabrication of Uniform Layer-by-layer Assemblies with Complementary Protein Cage Nanobuilding Blocks via Simple His-tag/metal Recognition. J. Mater. Chem. B, 2013, 1, 4504-4510.

3. Kang, Y. J., Park, D. C., Shin, H., Park, J., and Kang, S. Incorporation of Thrombin Cleavage Peptide into a Protein Cage for Constructing a Protease-responsive Multifunctional Delivery Nanoplatform. Biomacromolecules, 2012, 13, 4057-4064

2. #Kang, H.J., #Kang, Y.J., Lee, Y.M., Shin, H., Chung, S.J., and Kang, S. Developing an Antibody-binding Protein Cage as a Molecular Recognition Drug Modular Nanoplatform. Biomaterials, 2012, 33, 5423-5430

# Equal contribution

1. Kang, Y.J., Uchida, M., Shin, H.,Douglas, T. and Kang, S. Biomimetic FePt nanoparticle synthesis within Pyrococcus furiosus ferritins and their layer-by-layer formation. Soft Matter, 2011, 7, 11078-11081